# Efficacy and tolerability of vildagliptin as add‐on therapy to metformin in Chinese patients with type 2 diabetes mellitus

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-tolerability-of-vildagliptin-as-add-on-therapy-to-metformin-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Changyu Pan,Xiaoping Xing,Ping Han,S.X Zheng,Jianhua Ma,Jinhui Liu,Xiaoyi Lv,J. Lu,Giovanni Bader,on behalf of all investigators |
| Citations | 80 |
| DOI | 10.1111/j.1463-1326.2012.01593.x |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2081947250 |
| PMID | 22369287 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Xiaoping Xing](https://scholariq.org/researchers/xiaoping-xing/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.